Cited by 166HIV/AIDS Research and InterventionsMedication Adherence and ComplianceHIV/AIDS drug development and treatment

A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy

Open access
Claborn, Kasey R., Meier, Ellen, Miller, Mary Beth, Leffingwell, Thad R.·2015·Psychology, Health & Medicine

Abstract

HIV treatment requires lifelong adherence to medication regimens that comprise inconvenient scheduling, adverse side effects, and lifestyle changes. Antiretroviral adherence and treatment fatigue have been inextricably linked. Adherence in HIV-infected populations has been well investigated; however, little is known about treatment fatigue. This review examines the current state of the literature on treatment fatigue among HIV populations and provides an overview of its etiology and potential consequences. Standard systematic research methods were used to gather published papers on treatment fatigue and HIV. Five databases were searched using PRISMA criteria. Of 1557 studies identified, 21 met the following inclusion criteria: (a) study participants were HIV-infected; (b) participants were prescribed antiretroviral medication; (c) the article referenced treatment fatigue; (d) the article was published in a peer-reviewed journal; and (e) text was available in English. Only seven articles operationally defined treatment fatigue, with three themes emerging throughout the definitions: (1) pill burden; (2) loss of desire to adhere to the regimen; and (3) nonadherence to regimens as a consequence of treatment fatigue. Based on these studies, treatment fatigue may be defined as "decreased desire and motivation to maintain vigilance in adhering to a treatment regimen among patients prescribed long-term protocols." The cause and course of treatment fatigue appear to vary by developmental stage. To date, only structured treatment interruptions have been examined as an intervention to reduce treatment fatigue in children and adults. No behavioral interventions have been developed to reduce treatment fatigue. Further, only qualitative studies have examined treatment fatigue conceptually. Studies designed to systematically assess treatment fatigue are needed. Increased understanding of the course and duration of treatment fatigue is expected to improve adherence interventions, thereby improving clinical outcomes for individuals living with HIV.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/13548506.2014.945601

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Research on treatment burden and treatment fatigue has largely centered on health behaviors such as medication adherence and exercise compliance in patients with chronic disease.

    “To date, research on treatment burden and treatment fatigue has largely centered on health behaviors such as medication adherence (Claborn et al., 2015) and exercise compliance in patients with chronic disease (Dobkin et al., 2005, 2006; Heckman et al., 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Arem HN Nakyanjo N Kagaayi J Mulamba J Nakigozi G Serwadda D Chang LW Peer health workers and AIDS care in Rakai, Uganda: A mixed methods operations research evaluation of a cluster-randomized trial AIDS Patient Care & STDs 2011 25 719 724 21391828 PMC3216066
  2. Bagenda A Barlow-Mosha L Bagenda D Sakwa R Fowler MG Musoke PM Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda Annals of Tropical Paediatrics 2011 31 235 245 21781419
  3. Cohen CJ Colson AE Sheble-Hall AG McLaughlin KA Morse GD Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study HIV Clinical Trials 2007 8 19 23 17434845
  4. Cook PF Sousa KH Patterns of change in symptom clusters with HIV disease progression Journal of Pain and Symptom Management 2011 42 12 23 21429701 PMC3132274
  5. Danel C Moh R Minga A Anzian A Ba-Gomis O Kanga C Anglaret X CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial Lancet 2006 367 9527 1981 1989 16782488
  6. DiMascio M Markowitz M Louie M Hogan C Hurley A Chung C Ho DD Perelson AS Viral blip dynamics during highly active antiretroviral therapy Journal of Virology 2003 77 12165 12172 14581553 PMC253757
  7. Eron J Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions The Journal of Infectious Diseases 2008 197 Suppl 3 S261 S271 18447612
  8. Fox MP McCoy K Larson BA Rosen S Bii M Sigei C Simon JL Improvements in physical wellbeing over the first two years on antiretroviral therapy in Western Kenya AIDS Care 2010 22 137 145 20390492 PMC2856113
  9. Friedland GH HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice Journal of Acquired Immune Deficiency Syndromes (1999) 2006 43 Suppl 1 S3 S9 17133202
  10. Gardner EM Burman WJ Maravi ME Davidson AJ Durability of Adherence to Antiretroviral Therapy on Initial and Subsequent Regimens AIDS Patient Care And Stds 2006 20 9 628 636 16987049 PMC1976283
  11. Ickovics JR Meade CS Adherence to antiretroviral therapy among patients with HIV: A critical link between behavioral and biomedical sciences Journal of Acquired Immune Deficiency Syndromes 2002 31S 98 102 12562029
  12. Johnson MO Stallworth T Neilands TB The drugs or the disease? Causal attributions of symptoms held by HIV positive adults on HAART AIDS and Behavior 2003 7 109 117 14586196
  13. Lalezari JP DeJesus E Northfelt DW Richmond G Wolfe P Haubrich R Delehanty J A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir, and efavirenz in non-nucleoside reverse transcriptase inhibitor-naïve HIV-infected adults Antiviral Therapy 2003 8 279 287 14518696
  14. Lemiale F Korokhov N Lentiviral vectors for HIV disease prevention and treatment Vaccine 2009 27 25 26 19201386
  15. Lundgren J Babiker A El-Sadr W Emery S Grund B Neaton J Phillips A Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up The Journal of Infectious Diseases 2008 197 8 1145 1155 18476293
  16. Marhefka SL Tepper VJ Brown JL Farley JJ Caregiver psychosocial characteristics and children’s adherence to antiretroviral therapy AIDS Patient Care and STDs 2006 20 429 437 16789856
  17. McMahon D Lederman M Haas DW Haubrich R Stanford J Cooney E Horton J Mellors JW Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naïve HIV-1-infected adults Antiviral Therapy 2001 6 105 114 11491415
  18. Mellins C Brackis-Cott E Dolezal C Abrams E The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children The Pediatric Infectious Disease Journal 2004 23 11 1035 1041 15545859
  19. Merzel C VanDevanter N Irvine M Adherence to antiretroviral therapy among older children and adolescents with HIV: A qualitative study of psychosocial contexts AIDS Patient Care and STDs 2008 22 977 987 19072104
  20. Miramontes H Treatment fatigue The Journal of the Association of Nurses in AIDS Care 2001 12S 90 92 11563246
  21. Miron RE Smith RJ Modelling imperfect adherence to HIV induction therapy BMC Infectious Diseases 2010 10 6 20064271 PMC2833165
  22. Noguero A Moren C Rovira N Sanchez E Garrabou G Nicolas M Fortuny C Evolution of mitochondrial DNA content after planned interruption of HAART in HIV-infected pediatric patients AIDS Research and Human Retroviruses 2010 26 1015 1018 20707732
  23. Ostrop NJ Hallett KA Gill MJ Long-term patient adherence to antiretroviral therapy The Annals of Pharmacotherapy 2000 34 703 709 10860129
  24. Pai NP Lawrence J Reingold AL Tulsky JP Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults Cochrane Database of Systematic Reviews 2006 3 CD006148 16856117 PMC7390496
  25. Paterson DL Swindells S Mohr J Brester M Vergis EN Squier C Singh N Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Annals of Internal Medicine 2000 133 1 21 30 10877736
  26. Pinzón-Iregui M Beck-Sagué C Malow R Disclosure of their HIV status to infected children: a review of the literature Journal Of Tropical Pediatrics 2013 59 2 84 89 23070738 PMC3693505
  27. Ruane PJ Parenti DM Margolis DM Shepp DH Babinchak TJ Van Kempen AS Hernandez JE Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adults HIV Clinical Trials 2003 4 231 243 12916008
  28. Saitoh A Foca M Viani RM Heffernan-Vacca S Vaida F Lujan-Zilbermann J Spector SA Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection Pediatrics 2008 121 e513 e521 18310171
  29. Skiest DJ Krambrink A Su Z Robertson KR Margolis DM Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: Results of ACTG 5170 Journal of Acquired Immune Deficiency Syndrome 2008 49 377 383 PMC2634828 18931631
  30. Thompson IR Bidgood P Petroczi A Denholm-Price JC Fielder MD An alternative methodology for the prediction of adherence to anti-HIV treatment AIDS Research and Therapy 2009 6 9 19486507 PMC2698819
  31. Van Dyk AC Treatment adherence following national antiretroviral rollout in South Africa African Journal of AIDS Research 2010 9 235 247 25860628

Cited by

Sorted by citations

Authors
Claborn, K. R., Meier, E., Miller, M. B., & Leffingwell, T. R.
Affiliations
  • Brown University (US)
  • Oklahoma State University (US)
Corresponding author
Claborn, Kasey R.
Venue
Psychology, Health & Medicine
Published
2014-08-11
Volume
20
Issue
3
Pages
255-265
ISSN
  • 1354-8506 (ISSN-L)
  • 1465-3966
OpenAlex
W2080436266
Cited by
166
References
1
Citations by year
2026: 14 · 2025: 16 · 2024: 12 · 2023: 12 · 2022: 16 · 2021: 24 · 2020: 21 · 2019: 13 · 2018: 10 · 2017: 13 · 2016: 8 · 2015: 6 · 2014: 1
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Psychology Health & Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Alcohol Abuse and Alcoholism (T32AA007459)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
treatment fatigue, HIV infection, antiretroviral therapy, medication adherence, medication burden, treatment interruption, adherence interventions, HIV-infected children
MeSH terms
Humans, HIV Infections, Antiretroviral Therapy, Highly Active, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review